Surveillance after resection of pancreatic ductal adenocarcinoma : How to do it and what are the benefits?
(2024) In Scandinavian Journal of Surgery- Abstract
Background and objective: Surveillance following resection with curative intent of pancreatic cancer varies widely, and supporting evidence is limited. Recurrence is although frequent, not at least during the first 2 years. Surveillance may be costly, but evidence on how this influences overall survival is not fully elucidated. Methods, Results: There are reports implying that signs of biological recurrence (increasing CA 19-9) precede radiologically demonstrated recurrence by months. Conclusions: The possibility of initiating salvage therapy earlier is discussed, potentially based on improved future biomarker panels.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/0055ecb2-0c3c-4c6c-8cb6-f2fa78b8c37d
- author
- Andersson, Roland LU ; Ansari, Daniel LU and Haglund, Caj
- organization
- publishing date
- 2024
- type
- Contribution to journal
- publication status
- epub
- subject
- keywords
- benefit, biomarkers, Pancreatic cancer, resection, surveillance
- in
- Scandinavian Journal of Surgery
- publisher
- Finnish Surgical Society
- external identifiers
-
- pmid:38288556
- scopus:85184220267
- ISSN
- 1457-4969
- DOI
- 10.1177/14574969231156353
- language
- English
- LU publication?
- yes
- id
- 0055ecb2-0c3c-4c6c-8cb6-f2fa78b8c37d
- date added to LUP
- 2024-03-08 12:08:02
- date last changed
- 2024-04-20 05:51:51
@article{0055ecb2-0c3c-4c6c-8cb6-f2fa78b8c37d, abstract = {{<p>Background and objective: Surveillance following resection with curative intent of pancreatic cancer varies widely, and supporting evidence is limited. Recurrence is although frequent, not at least during the first 2 years. Surveillance may be costly, but evidence on how this influences overall survival is not fully elucidated. Methods, Results: There are reports implying that signs of biological recurrence (increasing CA 19-9) precede radiologically demonstrated recurrence by months. Conclusions: The possibility of initiating salvage therapy earlier is discussed, potentially based on improved future biomarker panels.</p>}}, author = {{Andersson, Roland and Ansari, Daniel and Haglund, Caj}}, issn = {{1457-4969}}, keywords = {{benefit; biomarkers; Pancreatic cancer; resection; surveillance}}, language = {{eng}}, publisher = {{Finnish Surgical Society}}, series = {{Scandinavian Journal of Surgery}}, title = {{Surveillance after resection of pancreatic ductal adenocarcinoma : How to do it and what are the benefits?}}, url = {{http://dx.doi.org/10.1177/14574969231156353}}, doi = {{10.1177/14574969231156353}}, year = {{2024}}, }